Theranos Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 416

Employees

  • Latest Deal Type
  • Liquidation

Theranos General Information

Description

Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of diagnostic information. The company's system creates an integrated infrastructure for real-time testing, decision-making, and individualized therapy, enabling laboratories to process early detection and intervention.

Contact Information

Formerly Known As
RealTime Cures
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Corporate Office
  • 1701 Page Mill Road
  • Palo Alto, CA 94304
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theranos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 05-Sep-2018 00.000 Completed Bankruptcy: Liquidation
10. Debt - General 23-Dec-2017 00000 00.000 Completed Generating Revenue
9. Secondary Transaction - Private 27-Mar-2017 00000 Completed Generating Revenue
8. Later Stage VC (Series C3) 01-Oct-2015 00000 000.00 Cancelled Generating Revenue
7. Later Stage VC 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series C2) 04-Feb-2014 00000 00000 00.00 Completed Generating Revenue
5. Later Stage VC 28-Mar-2013 0000 00000 00.000 Completed Generating Revenue
4. Later Stage VC 08-Jul-2010 0000 000.00 00.000 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Nov-2006 $32.4M $48.4M 00000 Completed Startup
2. Early Stage VC (Series B) 16-Feb-2006 $9.1M $16M 0000 Completed Startup
To view Theranos’s complete valuation and funding history, request access »

Theranos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C3 00,000,000 00.000000 000 000 00 000 0.000
Series C2 00,000,000 00.000000 000 000 00 000 00.000
Series C1 00,000,000 00.000000 00 00 00 00 0.000
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 54,162,965 $0.000100 $0.18 $0.18 1x $0.18 10.03%
Series A 46,320,045 $0.000100 $0.15 $0.15 1x $0.15 8.58%
To view Theranos’s complete cap table history, request access »

Theranos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of
Medical Supplies
Palo Alto, CA
416 As of 2023
00.000
000000000000 00.000

000 00

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000 000000000
Fremont, CA
00 As of 0000
00000000000

00000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000000000 00000000
Secaucus, NJ
00000 As of 0000
00.00
000000000 00 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Theranos Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ARK Diagnostics Formerly VC-backed Fremont, CA 00 00000000000
Quest Diagnostics Corporation Secaucus, NJ 00000 00.00 000000000 00 00.00
Abaxis Formerly VC-backed Union City, CA 000 000.00 000000&0 000.00
Everly Health Venture Capital-Backed Austin, TX 000 00000 00000000000 00000
To view Theranos’s complete competitors history, request access »

Theranos Patents

Theranos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2994826-A1 Transfer vessel and methods for reducing sample loss Pending 04-Aug-2015 0000000000
JP-2018528411-A Systems, devices, and methods for collecting, transporting and handling bodily fluid samples Inactive 21-Jul-2015 00000000
CA-2993316-A1 Systems, devices, and methods for bodily fluid sample collection, transport, and handling Pending 21-Jul-2015 00000000
JP-2017531424-A Hybrid multi-step nucleic acid amplification Inactive 17-Sep-2014 000000000 0
JP-2017532030-A Diagnostic method and composition Inactive 17-Sep-2014 C12Q1/707
To view Theranos’s complete patent history, request access »

Theranos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theranos FAQs

  • When was Theranos founded?

    Theranos was founded in 2003.

  • Who is the founder of Theranos?

    Elizabeth Holmes and Henry Kissinger are the founders of Theranos.

  • Where is Theranos headquartered?

    Theranos is headquartered in Palo Alto, CA.

  • What is the size of Theranos?

    Theranos has 416 total employees.

  • What industry is Theranos in?

    Theranos’s primary industry is Medical Supplies.

  • Is Theranos a private or public company?

    Theranos is a Private company.

  • What is Theranos’s current revenue?

    The current revenue for Theranos is 00000.

  • How much funding has Theranos raised over time?

    Theranos has raised $1.05B.

  • Who are Theranos’s competitors?

    ARK Diagnostics, Quest Diagnostics, Abaxis, and Everly Health are competitors of Theranos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »